0 CHECKOUT

Philippines Pharmaceuticals and Healthcare Report Q4 2015

  • ID: 3388372
  • September 2015
  • Region: Philippines
  • 132 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • MediChem Pharmaceuticals
  • Merck & Co
  • Novartis
  • Pascual Laboratories
  • Pfizer
  • Sanofi
  • MORE

The proposed 2016 government budget will be positive for the Philippines healthcare sector.

The budget proposes a significant increase in funds allocated to the Department of Health which will enable authorities to finance the expansion of the country's health insurance scheme and upgrade medical facilities in the country. These two thrusts collectively address some of the key impediments to healthcare access in the Philippines and will reinforce commercial opportunities for pharmaceutical companies operating in the country. However, further price caps on high-value medicines and poor intellectual property protection continue to pose a substantial risk for multinational drugmakers.

Headline Expenditure Projections
- Pharmaceuticals: PHP145.05bn (USD3.28bn) in 2014, rising to PHP150.49bn (USD3.32bn) in 2015;
+3.8% in local currency terms and +1.0% in US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: PHP563.49bn (USD12.75bn) in 2014, rising to PHP623.75bn (USD13.74bn) in 2015;
+10.7% in local currency terms and +7.8% in US dollar terms. Revised downwards from last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • MediChem Pharmaceuticals
  • Merck & Co
  • Novartis
  • Pascual Laboratories
  • Pfizer
  • Sanofi
  • MORE

SWOT

Political

Economic

Operational Risk

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Estonia 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2011-2019)

Prescription Drug Market Forecast
Table: Leading Anatomical Therapeutic Chemical (ATC) Groups By Pharmaceutical Sales, 2004-2010 (%)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Estonia 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Estonia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Estonia 2013-2019)

Key Risks To Forecast Scenario

Macroeconomic Forecasts

Economic Analysis
Table: Economic Activity (Estonia 2010-2019)

Industry Risk/Reward Indices

Central And Eastern Europe Risk/Reward Index - Q4 2015

Estonia Risk/Reward Index

Rewards

Risks

Market Overview

Industry Trends And Developments

Epidemiology
Table: Leading Causes Of Death, 2005-2010

Healthcare Sector

Healthcare Reform

Healthcare Provision
Table: Healthcare Resources (Estonia 2009-2014)
Table: Healthcare Personnel (Estonia 2009-2014)
Table: Healthcare Activity (Estonia 2009-2014)

Healthcare Funding
Table: HIF Healthcare Expenditure, 2006-2011 (EURmn)

Healthcare Insurance
Table: Reimbursement Spending By Key Therapeutic Area, 2010-2011 (EURmn)
Table: Medicinal Products Reimbursed For Insured Patients, 2009-2011 (EURmn)

Healthcare Tourism

Research And Development
Table: Members Of EBio, 2011

Clinical Trials
Table: Number Of Clinical Trials, 1991-2011

Regulatory Development
Table: Key Health Insurance Indicators, 2007-2011
Table: Expenditure By Reimbursed Prescription Medicinal Products, 2005-2010 (EEK '000)

Competitive Landscape
Table: Members Of The Association Of International Pharmaceutical Manufacturers In Estonia

Generic Drugmakers

Pharmaceutical Distribution

Pharmaceutical Retail Sector
Table: Pharmacies And Pharmacy Market Ratios, 2004-2009

Company Profile

GlaxoSmithKline

Grindeks (incorporating Tallinn Pharmaceutical Plant)

Merck & Co

Novartis

Pfizer

Sanofi

Demographic Forecast
Table: Population Headline Indicators (Estonia 1990-2025)
Table: Key Population Ratios (Estonia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Estonia 1990-2025)
Table: Population By Age Group (Estonia 1990-2025)
Table: Population By Age Group % (Estonia 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

GlaxoSmithKline Philippines
MediChem Pharmaceuticals
Merck & Co
Novartis
Pacific Pharmaceutical Generics
Pascual Laboratories
Pfizer
Sanofi
Unilab

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S